Of the 50 patients, 18 developed symptoms during follow-up examinations.
The study found:
• The newly symptomatic group had a mean tear size of 10.6 mm.
• The still-asymptomatic group had a mean tear size of 3.3 mm.
• The rate of progression to advanced muscle atrophy was 35 percent in the newly symptomatic group and 12 percent in the group of still-asymptomatic patients
• The rate of fatty degeneration was 35 percent in the newly symptomatic group and 4 percent in the group of still-asymptomatic patients.
• The rate of pathology of the long head of the biceps tendon was 33 percent in the newly symptomatic group and 6 percent in the group of still-asymptomatic patients.
More Articles on Sports Medicine:
Dr. James Cotton Joins Coastal Orthopedics & Sports Medicine/Pain Management
3 Things to Know About Long-Term Success of Elbow Surgery in Baseball Players
5 Orthopedic Practices Expanding or Adding Physicians
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
